Related Experiment Video

Updated: Aug 14, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

Prostaglandin D2 mediates neuronal damage by amyloid-beta or prions which activates microglial cells

Clive Bate1, Sarah Kempster, Alun Williams

  • 1Department of Pathology and Infectious Diseases, Royal Veterinary College, Hawkshead Lane, North Mymms, Herts, AL9 7TA, UK. cbate@rvc.ac.uk

Neuropharmacology
|November 18, 2005
PubMed

Insights

Sub-lethal prion protein and amyloid-beta peptides damage neurons, triggering microglial cell activation and death. Prostaglandin D2 and E2 mediate this neurotoxicity via COX-1 and DP receptors, highlighting potential therapeutic targets.

Area of Science:

  • Neuroscience
  • Immunology
  • Biochemistry

Background:

  • Microglial cells are key immune cells in the central nervous system.
  • Amyloid-beta and prion protein peptides are implicated in neurodegenerative diseases like Alzheimer's and prion diseases.
  • Neuronal damage and death are central features of these conditions.

Purpose of the Study:

  • To investigate the mechanism by which microglial cells induce neuronal death.
  • To identify the role of specific inflammatory mediators in this process.
  • To explore potential therapeutic interventions targeting this pathway.

Main Methods:

  • Co-culture systems of neurons and microglial cells.
  • Incubation with human prion protein (HuPrP82-146) and amyloid-beta1-42 peptides.
  • Assessment of neuronal damage and survival.
  • Analysis of microglial activation markers like interleukin-6 (IL-6).
  • Use of cyclo-oxygenase (COX)-1 inhibitors and prostaglandin receptor agonists/antagonists.

Main Results:

  • Sub-lethal HuPrP82-146 and amyloid-beta1-42 induced neuronal damage and subsequent microglial activation.
  • Damaged neurons exhibited phenotypic changes, binding a CD14-IgG chimera.
  • COX-1 inhibition protected neurons and reduced microglial activation.
  • Prostaglandin D2 (PGD2) and E2 (PGE2) mimicked the neurotoxic effects.
  • DP receptor activation by PGD2 was crucial for neuronal damage and microglial activation, while DP receptor antagonism was neuroprotective.

Conclusions:

  • Prostaglandin D2, produced via COX-1 activation by HuPrP82-146 or amyloid-beta1-42, drives neuroinflammation and neuronal loss.
  • Phenotypic changes in neurons are key to initiating microglial-mediated neurotoxicity.
  • Targeting the COX-1/PGD2/DP receptor pathway offers a potential therapeutic strategy for neurodegenerative diseases.

More Related Videos

Adipose-Derived Mesenchymal Stromal Cells Co-Cultured with Primary Mixed Glia to Reduce Prion-Induced Inflammation10:40

Adipose-Derived Mesenchymal Stromal Cells Co-Cultured with Primary Mixed Glia to Reduce Prion-Induced Inflammation

Published on: August 11, 2023

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons06:23

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Published on: October 30, 2018

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...